arGEN-X Aktie
619,40EUR | -3,00EUR | -0,48% |
WKN DE: A11602 / ISIN: NL0010832176
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 336 | 650 | 843 | 1 148 | 1 599 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,11 | 0,65 | 0,46 | 0,99 | 1,27 |
Bilanz (in Mio. EUR) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 1 676 | 2 236 | 2 599 | 3 733 | 4 716 |
Summe Anlagevermögen | 181 | 270 | 337 | 379 | 1 274 |
Summe Aktiva | 1 858 | 2 506 | 2 937 | 4 112 | 5 990 |
Bilanz (in Mio. EUR) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 493 | 278 | 300 | 403 | 680 |
Summe Eigenkapital | 1 364 | 2 228 | 2 636 | 3 709 | 5 310 |
Summe Passiva | 1 858 | 2 506 | 2 937 | 4 112 | 5 990 |
Adresse
Laarderhoogtweg 25, 1101 EB Amsterdam | |
Telefon | +31 (76) 303-04-88 |
Internet | http://www.argen-x.com |
Management
Ana Cespedes
Independent Non-Executive Director |
Anthony Adam Rosenberg
Independent Non-Executive Director |
Arjen Lemmen
Vice President-Corporate Development & Strategy |
Beth Delgiacco
VP-Corporate Communications & Investor Relations |
Brian L. Kotzin
Non-Executive Director |
Camilla Sylvest
Independent Non-Executive Director |
Filip Borgions
Chief Technology Innovation Officer |
Hemamalini Moorthy
General Counsel |
James M. Daly
Independent Non-Executive Director |
Joseph Donald deBethizy
Vice Chairman |
Karen Massey
Chief Operating Officer |
Karl Gubitz
Chief Financial Officer |
Luc Truyen
Chief Medical Officer |
Marc Schorpion
Global Head-Human Resources |
Pamela M. Klein
Independent Non-Executive Director |
Peter K. M. Verhaeghe
Non-Executive Chairman |
Peter Ulrichts
Chief Scientific Officer |
Steve E. Krognes
Independent Non-Executive Director |
Tim van Hauwermeiren
Chief Executive Officer & Executive Director |